ロード中...
Augmenting extinction learning with d-cycloserine reduces return of fear: a randomized, placebo-controlled fMRI study
d-cycloserine (DCS), a partial NMDA-receptor agonist, seems to be a promising enhancer for exposure therapy in anxiety disorders. It has been tested successfully in animal models of fear extinction, where DCS enhanced extinction learning. Applied in clinical studies, results of DCS-augmented exposur...
保存先:
| 出版年: | Neuropsychopharmacology |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6969173/ https://ncbi.nlm.nih.gov/pubmed/31634897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-019-0552-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|